ABL Bio Valuation
| 298380 Stock | KRW 41,150 1,400 3.52% |
At this time, the entity appears to be overvalued. ABL Bio shows a prevailing Real Value of W32676.0 per share. The current price of the entity is W41150.0. Our model approximates the value of ABL Bio from examining the entity fundamentals such as Shares Outstanding of 45.3 M, operating margin of (6.16) %, and Shares Owned By Institutions of 12.89 % as well as evaluating its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that ABL Bio's price fluctuation is very steady at this time. Calculation of the real value of ABL Bio is based on 3 months time horizon. Increasing ABL Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since ABL Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ABL Stock. However, ABL Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 41150.0 | Real 32676.0 | Hype 41150.0 | Naive 41085.7 |
The real value of ABL Stock, also known as its intrinsic value, is the underlying worth of ABL Bio Company, which is reflected in its stock price. It is based on ABL Bio's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of ABL Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of ABL Bio helps investors to forecast how ABL stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ABL Bio more accurately as focusing exclusively on ABL Bio's fundamentals will not take into account other important factors: ABL Bio Total Value Analysis
ABL Bio is presently forecasted to have takeover price of 866.33 B with market capitalization of 958.17 B, debt of 72.32 M, and cash on hands of 21.59 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the ABL Bio fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
866.33 B | 958.17 B | 72.32 M | 21.59 B |
ABL Bio Investor Information
About 32.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. Based on the analysis of ABL Bio's profitability, liquidity, and operating efficiency, ABL Bio is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.ABL Bio Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. ABL Bio has an asset utilization ratio of 8.15 percent. This suggests that the Company is making W0.0815 for each dollar of assets. An increasing asset utilization means that ABL Bio is more efficient with each dollar of assets it utilizes for everyday operations.ABL Bio Ownership Allocation
ABL Bio holds a total of 45.3 Million outstanding shares. ABL Bio retains considerable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the entity is less than the current market value, you may not be able to make money on it.ABL Bio Profitability Analysis
The company reported the revenue of 5.33 B. Net Loss for the year was (43.56 B) with profit before overhead, payroll, taxes, and interest of 8.06 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates ABL Bio's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in ABL Bio and how it compares across the competition.
About ABL Bio Valuation
The stock valuation mechanism determines ABL Bio's current worth on a weekly basis. Our valuation model uses a comparative analysis of ABL Bio. We calculate exposure to ABL Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ABL Bio's related companies.ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. ABL Bio is traded on Korean Securities Dealers Automated Quotations in South Korea.
8 Steps to conduct ABL Bio's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates ABL Bio's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct ABL Bio's valuation analysis, follow these 8 steps:- Gather financial information: Obtain ABL Bio's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine ABL Bio's revenue streams: Identify ABL Bio's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research ABL Bio's industry and market trends, including the size of the market, growth rate, and competition.
- Establish ABL Bio's growth potential: Evaluate ABL Bio's management, business model, and growth potential.
- Determine ABL Bio's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate ABL Bio's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for ABL Stock analysis
When running ABL Bio's price analysis, check to measure ABL Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABL Bio is operating at the current time. Most of ABL Bio's value examination focuses on studying past and present price action to predict the probability of ABL Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABL Bio's price. Additionally, you may evaluate how the addition of ABL Bio to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Commodity Directory Find actively traded commodities issued by global exchanges |